CRISPR Therapeutics reviews

Thanks for leaving a review. It is nice to hear you appreciated the benefits package and office location while working for us. CRISPR continues to invest in our Immuno-oncology programs, and we have upcoming program updates for Immuno-oncology and data readouts across many program areas this year. We are also proud of our ongoing cardiovascular clinical trials, which could offer a potential one-time treatment to help reduce the risk of severe cardiovascular events such as heart attacks and strokes. We have shared your feedback with the team and wish you the best in your next position.

We appreciate you taking the time to provide a review. It is good to hear you enjoy working with your colleagues. CRISPR’s goals are focused on delivering innovation across all our disease areas and our platform, presenting the need to pivot periodically as we build towards this goal. We communicate these goals annually and periodically discuss them during company meetings and we post them to our internal company site for visibility. Please do not hesitate to reach out to your functional leader, manager and/or HR to provide further feedback.